Form 4: Guardant Health CCO Chris Freeman Equity Vesting

Sentiment:

Statement of Changes in Beneficial Ownership


Chief Commercial Officer Chris Freeman acquired 1,402 shares of Guardant Health common stock via restricted stock unit vesting.

Summary

  • Chris Freeman, Chief Commercial Officer of Guardant Health, Inc., acquired 1,402 shares of common stock upon the vesting of restricted stock units (RSUs) on June 15, 2026.
  • The company withheld 594 shares at a price of $129.82 per share to satisfy tax withholding obligations related to the vesting event.
  • Following these transactions, the reporting person holds 61,101 shares of common stock directly.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as it represents a routine administrative transaction related to executive compensation rather than a change in company outlook.

Positives

  • The transaction reflects the standard vesting of equity compensation, indicating alignment between executive incentives and long-term company performance.

Negatives

  • The company withheld 594 shares to cover tax liabilities, which is a standard administrative procedure but reduces the net shares added to the executive's holdings.

Risks

  • None identified; this is a routine disclosure of equity compensation activity.

Future Outlook

Not applicable; this is a retrospective disclosure of an equity transaction.

Industry Context

StockSavvy.ai notes that routine equity vesting disclosures for C-suite executives are standard corporate governance practices and do not typically signal changes in strategic direction or market sentiment.

Comparison to Industry Standards

  • The tax withholding mechanism used here is consistent with standard equity compensation practices across the biotechnology and healthcare sectors.

Stakeholder Impact

  • Minimal impact on shareholders as this is a standard equity compensation event.

Next Steps

  • No further actions required; this is a completed transaction.

Key Dates

DateDescription
06/09/2023Original grant date of the restricted stock unit award.
06/15/2024Initial vesting date of 33% of the RSU award.
06/15/2026Transaction date for the vesting and tax withholding of shares.
06/16/2026Date of filing for the Form 4.

Keywords

Guardant Health, GH, Form 4, Insider Trading, Equity Compensation, Restricted Stock Units, Chris Freeman

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.